SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM 1991 Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 325:16881695.
  • 2
    Schwindinger WF, Francomano CA, Levine MA 1992 Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. Proc Natl Acad Sci USA 89:51525156.
  • 3
    Shenker A, Weinstein LS, Sweet DE, Spiegel AM 1994 An activating Gs alpha mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome. J Clin Endocrinol Metab 79:750755.
  • 4
    Ringel MD, Schwindinger WF, Levine MA 1996 Clinical implications of genetic defects in G proteins. The molecular basis of McCune-Albright syndrome and Albright hereditary osteodystrophy. Medicine (Baltimore) 75:171184.
  • 5
    Spiegel AM 1996 Defects in G protein-coupled signal transduction in human disease. Annu Rev Physiol 58:143170.
  • 6
    Spiegel AM 1997 Inborn errors of signal transduction: Mutations in G proteins and G protein-coupled receptors as a cause of disease. J Inherit Metab Dis 20:113121.
  • 7
    Spiegel AM 1997 The molecular basis of disorders caused by defects in G proteins. Horm Res 47:8996.
  • 8
    Boothroyd CV, Grimmond SM, Cameron DP, Hayward NK 1995 G protein mutations in tumours of the pituitary, parathyroid, and endocrine pancreas. Biochem Biophys Res Commun 211:10631070.
  • 9
    Boston BA, Mandel S, LaFranchi S, Bliziotes M 1994 Activating mutation in the stimulatory guanine nucleotide-binding protein in an infant with Cushing's syndrome and nodular adrenal hyperplasia. J Clin Endocrinol Metab 79:890893.
  • 10
    Derwahl M 1996 Molecular aspects of the pathogenesis of nodular goiters, thyroid nodules and adenomas. Exp Clin Endocrinol Diabetes 104 Suppl 4:3235.
  • 11
    Gorelov VN, Dumon K, Barteneva NS, Palm D, Roher HD, Goretzki PE 1995 Overexpression of Gs alpha subunit in thyroid tumors bearing a mutated Gs alpha gene. J Cancer Res Clin Oncol 121:219224.
  • 12
    Lyons J, Landis CA, Harsh G, Vallar L, Grunewald K, Feichtinger H, Duh QY, Clark OH, Kawasaki E, Bourne HR, McCormick F. 1990 Two G protein oncogenes in human endocrine tumors. Science 249:655659.
  • 13
    Huvos AG 1991 Bone Tumors: Diagnosis, Treatment and Prognosis. Saunders, New York, NY, U.S.A
  • 14
    Alman BA, Greel DA, Wolfe HJ 1996 Activating mutations of Gs protein in monostotic fibrous lesions of bone. J Orthop Res 14:311315.
  • 15
    Marie PJ, de Pollak C, Chanson P, Lomri A 1997 Increased proliferation of osteoblastic cells expressing the activating Gs alpha mutation in monostotic and polyostotic fibrous dysplasia. Am J Pathol 150:10591069.
  • 16
    Lichtenstein L, Jaffe HL 1942 Fibrous dysplasia of bone: A condition affecting one, several or many bones, the graver cases of which may present abnormal pigmentation of skin, premature sexual development, hyperthyroidism, and still other extraskeletal abnormalities. Arch Pathol 33:777797.
  • 17
    Jaffe HL 1958 Tumors and tumorous conditions of the bones and joints. Lea & Febiger, Philadelphia, PA, U.S.A
  • 18
    Bianco P, Kuznetsov S, Riminucci M, Fisher LW, Spiegel AM, Gehron Robey P 1998 Reproduction of human fibrous dysplasia of bone in immunocompromised mice by transplanted mosaics of normal and Gs-alpha mutated skeletal progenitor cells. J Clin Invest 101:17371744.
  • 19
    Riminucci M, Liu B, Corsi A, Shenker A, Spiegel AM, Gehron Robey P, Bianco P 1999 The histopathology of fibrous dysplasia of bone in patients with activating mutations of the Gs alpha gene: site-specific patterns and recurrent histological hallmarks. J Pathol 187:249258.
  • 20
    Kuznetsov SA, Krebsbach PH, Satomura K, Kerr J, Riminucci M, Benayahu D, Robey PG 1997 Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. J Bone Miner Res 12:13351347.
  • 21
    Krebsbach PH, Kuznetsov SA, Satomura K, Emmons RV, Rowe DW, Gehron Robey P 1997 Bone formation in vivo: Comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts. Transplantation 63:10591069.
  • 22
    Riminucci M, Fisher LW, Shenker A, Spiegel AM, Bianco P, Gehron Robey P 1997 Fibrous dysplasia of bone in the McCune-Albright syndrome: abnormalities in bone formation. Am J Pathol 151:15871600.
  • 23
    Boyde A, Maconnachie E, Reid SA, Delling G, Mundy GR 1986 Scanning electron microscopy in bone pathology: Review of methods, potential, and applications. Scan Electron Microsc Pt 4:15371554.
  • 24
    Spiegel AM 1996 Mutations in G proteins and G protein-coupled receptors in endocrine disease. J Clin Endocrinol Metab 81:24342442.
  • 25
    Happle R 1986 The McCune-Albright syndrome: A lethal gene surviving by mosaicism. Clin Genetics 29:321324.
  • 26
    Schwartz RA, Spicer MS, Leevy CB, Ticker JB, Lambert WC 1996 Cutaneous fibrous dysplasia: an incomplete form of the McCune-Albright syndrome. Dermatology 192:258261.
  • 27
    Liens D, Delmas PD, Meunier PJ 1994 Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. Lancet 343:953954.
  • 28
    Chapurlat RD, Delmas PD, Liens D, Meunier PJ 1997 Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. J Bone Miner Res 12:17461752.
  • 29
    Candeliere GA, Roughley PJ, Glorieux FH 1997 Polymerase chain reaction-based technique for the selective enrichment and analysis of mosaic arg201 mutations in G alpha s from patients with fibrous dysplasia of bone. Bone 21:201206.
  • 30
    Park YK, Unni KK, Beabout JW, Hodgson SF 1994 Oncogenic osteomalacia: A clinicopathologic study of 17 bone lesions. J Korean Med Sci 9:289298.
  • 31
    Dent CE, Gertner JM 1976 Hypophosphataemic osteomalacia in fibrous dysplasia. Q J Med 45:411420.
  • 32
    Ryan WG, Nibbe AF, Schwartz TB, Ray RD 1968 Fibrous dysplasia of bone with vitamin D resistant rickets: a case study. Metabolism 17:988998.
  • 33
    Kumar R 1997 Phosphatonin—a new phosphaturetic hormone? (Lessons from tumour-induced osteomalacia and X-linked hypophosphataemia) (Editorial). Nephrol Dial Transplant 12:1113.
  • 34
    Zung A, Chalew SA, Schwindinger WF, Levine MA, Phillip M, Jara A, Counts DR, Kowarski AA 1995 Urinary cyclic adenosine 3′,5′-monophosphate response in McCune-Albright syndrome: Clinical evidence for altered renal adenylate cyclase activity. J Clin Endocrinol Metab 80:35763581.